Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site revision was updated from v3.5.0 to v3.5.2. No visible changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added the term 'Mucopolysaccharidosis, MPS-II' and removed 'Mucopolysaccharidosis type 2' from the study's glossary/keywords.
    Difference
    0.1%
    Check dated 2026-03-25T21:25:03.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:41:25.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:01:12.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. The funding-lapse/open-status notice and the previous Revision: v3.4.1 entry were removed.
    Difference
    0.5%
    Check dated 2026-02-11T02:07:30.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operating status, and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-03T23:57:49.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.